Fig. 2From: Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS StudyEvaluation of cognitive dysfunction at baseline and at 6-month follow-up in the indicated groups of patients. Data are mean±SD; *: p < 0.05 vs. baseline; #: p < 0.05 vs. untreated; !: p < 0.05 vs. regular metformin, $: p < 0.05 vs. extended-release metformin men.Back to article page